July 30, 2021 - ROSEN LOGO.jpg
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – NNOX
07 oct. 2021 16h37 HE | The Rosen Law Firm PA
NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Nano-X...
Logo.jpg
Biofrontera provides update on clinical developments
22 juin 2021 09h00 HE | Biofrontera AG
Leverkusen, Germany, June 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today provides an...
Logo.jpg
ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend
13 mai 2021 16h05 HE | ProPhase Labs, Inc.
First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business Gross Profit Increases to $8.9 Million With Net Income of $1.1 Million or $0.07 Per Share ...
logo.png
Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
30 mars 2021 08h05 HE | Corbus Pharmaceuticals Holdings, Inc.
Topline data on schedule for Q2 2021Dermatomyositis is a rare and life-threatening autoimmune disease characterized by skin and muscle inflammation, and affects ~80,000 people in North America, EU,...
LOGO.jpg
QSAM Biosciences Closes Series B Preferred Private Placement; $2.5 Million in New Capital to Fund Upcoming Clinical Trials
28 janv. 2021 09h00 HE | QSAM Biosciences Inc.
Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear medicines for the treatment of cancer and related diseases,...
Lem Moyé launches a new press campaign for his 2017 novel ‘Saving Grace’
23 sept. 2020 00h00 HE | Trafford Publishing
CHANDLER, Ariz., Sept. 23, 2020 (GLOBE NEWSWIRE) -- A controversial viral infection offered as revolutionary therapy; a struggling family damaged in the name of science; a deadly disease rising from...
FDA ‘Black Box’ Lacks Transparency, Writes Editor of the Journal of American Physicians and Surgeons
22 juin 2020 10h41 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., June 22, 2020 (GLOBE NEWSWIRE) -- The Food and Drug Administration (FDA), the oldest “consumer protection agency” in our federal government, has lacked transparency for many years,...
Weigh Risks and Benefits of COVID-19 Response, Advises Association of American Physicians and Surgeons (AAPS)
21 mars 2020 13h16 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., March 21, 2020 (GLOBE NEWSWIRE) -- A new group called US Healthcare Providers for Federal Action Against COVID-19 has launched a petition on change.org calling for an immediate...
PAVMEDLOGONEW15OCT2018.png
PAVmed Provides Update on CarpX™ Clinical Safety Study
13 déc. 2019 09h30 HE | PAVmed Inc.
NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...
Logo_Biofrontera_AG.png
Biofrontera receives FDA approval for upscaling of batch size for Ameluz® production
08 janv. 2019 02h02 HE | Biofrontera AG
Leverkusen, Germany, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...